资源类型：
会议/期刊
收录情况：
◇ SCIE
◇ CPCI(ISTP)
文章类型：
会议摘要
作者：
Wang, Jinlin
*
;
Yi, Tienan
;
Dong, Youhong
;
Xu, Xinhua
;
Cao, Fengjun
;
Ran, Ruizhi
;
Yin, Yifa
;
Li, Yinping
;
Fu, Yang
;
Xu, Yanhua
;
Kuang, Li
;
Chen, Guiming
;
Qu, Guangqiao
;
Li, Jun
;
Luo, Zhiguo
;
Chen, Yuan
;
Song, Qibin
;
Chu, Qian
;
单位：
[1]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Tongji Med Coll, Wuhan, Peoples R China
肿瘤科
华中科技大学同济医学院附属同济医院
[2]XiangYang Cent Hosp, Xiangyang, Peoples R China
[3]Hubei Univ Med, Xiangyang 1 Peoples Hosp, Dept Oncol, Xiangyang, Peoples R China
[4]Peoples Hosp Yichang, Yichang, Peoples R China
[5]Hubei Univ Med, Renmin Hosp, Oncol Ctr, Lab Chinese Herbal Pharmacol, Shiyan, Peoples R China
[6]Cent Hosp Enshi Tujia & Miao Autonomous Prefactur, Dept Oncol, Enshi, Peoples R China
[7]Second Peoples Hosp YiChang, Dept Oncol, Yichang, Peoples R China
[8]Cent Hosp Xiao Gan, Resp Dept, Xiaogan, Peoples R China
[9]Xiangyang Hosp Tradit Chinese Med, Dept Oncol, Xiangyang, Peoples R China
[10]JinZhou Cent Hosp, Dept Oncol, Jingzhou, Peoples R China
[11]Dongfeng Hosp, Dept Oncol, Hubei Med Coll, Shiyan, Peoples R China
[12]JingMen 2 Peoples Hosp, Dept Oncol, Jingmen, Peoples R China
[13]Cent Hosp Xiao Gan, Dept Oncol, Xiaogan, Peoples R China
[14]Hubei Univ Med, Dept Clin Oncol, Taihe Hosp, Shiyan, Peoples R China
[15]Wuhan Univ, Renmin Hosp, Wuhan, Peoples R China
[16]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
华中科技大学同济医学院附属同济医院
出处：
JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):
ISSN：
0732-183X
WOS：
WOS:000863680304352
中科院(CAS)分区：
出版当年[2021]版：
大类
|
1 区
医学
小类
|
1 区
肿瘤学
最新[2025]版：
大类
|
1 区
医学
小类
|
1 区
肿瘤学
影响因子：
42.1
最新[2023版]
37.4
最新五年平均
44.544
出版当年[2020版]
33.883
出版当年五年平均
32.956
出版前一年[2019版]
50.739
出版后一年[2021版]
第一作者：
Wang, Jinlin
推荐引用方式(GB/T 7714)：
Wang Jinlin,Yi Tienan,Dong Youhong,et al.A real-world study update: Efficacy and safety of anlotinib for advanced non-small cell lung cancer[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):
APA：
Wang, Jinlin,Yi, Tienan,Dong, Youhong,Xu, Xinhua,Cao, Fengjun...&Chu, Qian.(2022).A real-world study update: Efficacy and safety of anlotinib for advanced non-small cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA：
Wang, Jinlin,et al."A real-world study update: Efficacy and safety of anlotinib for advanced non-small cell lung cancer".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)
医学